Pharmaron Beijing Co Ltd (PHBBF)
1.93
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Pharmaron Beijing Net Income (Quarterly): 50.88M for March 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
March 31, 2023 | 50.88M |
December 31, 2022 | 58.13M |
September 30, 2022 | 54.84M |
June 30, 2022 | 50.88M |
March 31, 2022 | 39.19M |
December 31, 2021 | 97.03M |
September 30, 2021 | 73.38M |
June 30, 2021 | 49.37M |
March 31, 2021 | 37.90M |
December 31, 2020 | 57.81M |
September 30, 2020 | 44.78M |
Date | Value |
---|---|
June 30, 2020 | 53.23M |
March 31, 2020 | 14.54M |
December 31, 2019 | 31.06M |
September 30, 2019 | 23.81M |
June 30, 2019 | 15.70M |
March 31, 2019 | 8.035M |
December 31, 2018 | 15.69M |
September 30, 2018 | 15.88M |
June 30, 2018 | 11.88M |
March 31, 2018 | 6.416M |
December 31, 2017 | 11.42M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
14.54M
Minimum
Mar 2020
97.03M
Maximum
Dec 2021
50.93M
Average
50.88M
Median
Net Income (Quarterly) Benchmarks
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 397.98M |
Total Expenses (Quarterly) | 335.19M |
EPS Diluted (Quarterly) | 0.0431 |